Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Latent Phase”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Not applicableLooking for participantsNCT06580327
What this trial is testing

Programmed Intermittent Epidural Bolus Compared With Continuous Infusion in Multiparous Women

Who this might be right for
Breakthrough Pain
Holy Family Hospital, Nazareth, Israel 186
Early research (Phase 1)Study completedNCT00078494
What this trial is testing

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Neoplasms
National Institutes of Health Clinical Center (CC) 99
Post-approval studies (Phase 4)Active Not RecruitingNCT05411744
What this trial is testing

One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

Who this might be right for
Latent TuberculosisEnd Stage Renal DiseaseRenal Transplant Candidate for Right Kidney+1 more
Rutgers, The State University of New Jersey 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07124559
What this trial is testing

Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 144
Post-approval studies (Phase 4)UnknownNCT00311220
What this trial is testing

Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers

Who this might be right for
TuberculosisLatent TuberculosisTuberculosis Contact+1 more
Taichung Veterans General Hospital 300
Not applicableStudy completedNCT05179915
What this trial is testing

Effect of Therapeutic Touch on Labor Pain and Hormone Levels

Who this might be right for
Therapeutic TouchChildbirth
Cukurova University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06640192
What this trial is testing

Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir

Who this might be right for
HIV-1-infection
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 24
Testing effectiveness (Phase 2)Study completedNCT04807543
What this trial is testing

Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes

Who this might be right for
Preterm Premature Rupture of Membrane
Ain Shams University 100
Not applicableLooking for participantsNCT03789253
What this trial is testing

Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer

Who this might be right for
Prostate Cancer Stage I
National Taiwan University Hospital 300
Testing effectiveness (Phase 2)WithdrawnNCT02176135
What this trial is testing

Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection

Who this might be right for
HIV
Vaccine and Gene Therapy Institute, Florida
Early research (Phase 1)Looking for participantsNCT05443178
What this trial is testing

Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

Who this might be right for
Tuberculosis Infection
University of Zurich 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05766267
What this trial is testing

Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis Infection
Centers for Disease Control and Prevention 288
Not applicableNot Yet RecruitingNCT07210970
What this trial is testing

Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients

Who this might be right for
Latent Tuberculosis InfectionEnd Stage Renal Disease (ESRD)Hemodialysis
Sohag University 200
Post-approval studies (Phase 4)Active Not RecruitingNCT05680415
What this trial is testing

Clinical Trial of Mica

Who this might be right for
Latent Tuberculosis Infection
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 6,800
Not applicableStudy completedNCT01863797
What this trial is testing

Trial on Early Induction Versus Expectant Management of Nulliparous Women With a Prolonged Latent Phase

Who this might be right for
Nulliparous Women With Prolonged Latent Phase
Karolinska Institutet 138
Testing effectiveness (Phase 2)Study completedNCT02933281
What this trial is testing

MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa

Who this might be right for
Tuberculosis
International AIDS Vaccine Initiative 144
Early research (Phase 1)Study completedNCT01967134
What this trial is testing

Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis

Who this might be right for
Latent TuberculosisLatent Tuberculosis Bacteriology and Histology Unknown
Aeras 25
Post-approval studies (Phase 4)Not Yet RecruitingNCT07631897
What this trial is testing

Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir Regimens

Who this might be right for
HIVArt TherapyTB - Tuberculosis
Shanghai Public Health Clinical Center 60
Large-scale testing (Phase 3)Study completedNCT04457297
What this trial is testing

Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection

Who this might be right for
Colorectal NeoplasmsTrifluridine and TipiracilCirculating Tumor DNA
National Cancer Center Hospital East 243
Testing effectiveness (Phase 2)Study completedNCT01136161
What this trial is testing

Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection

Who this might be right for
Latent Tuberculosis InfectionTuberculosis
Archivel Farma S.L. 95
Load More Results